UnitedHealth stock is trading -5.56% below its average target price of $539.25 after marking a 4.7% during today's evening session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $450.37 to $632.02 per share.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.9%. The stock's short ratio is 2.2. The company's insiders own 0.24% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 89.5%. In conclusion, we believe there is mixed market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 9% | 84,405,255 | $42,984,220,985 |
| 2024-03-31 | Blackrock Inc. | 8% | 73,670,533 | $37,517,456,355 |
| 2024-03-31 | State Street Corporation | 5% | 45,699,253 | $23,272,802,029 |
| 2024-03-31 | FMR, LLC | 4% | 35,668,357 | $18,164,467,834 |
| 2024-03-31 | Capital World Investors | 3% | 28,321,829 | $14,423,174,913 |
| 2024-03-31 | Price (T.Rowe) Associates Inc | 3% | 26,062,928 | $13,272,806,967 |
| 2024-03-31 | Wellington Management Group, LLP | 3% | 24,283,224 | $12,366,474,891 |
| 2024-03-31 | JP Morgan Chase & Company | 3% | 23,840,608 | $12,141,068,262 |
| 2024-03-31 | Morgan Stanley | 2% | 20,189,832 | $10,281,874,041 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 18,944,660 | $9,647,757,736 |
